Promising companies aim to pair up with funders

Two Kalamazoo companies will soon pitch products and plans to venture capitalists looking to invest their money.

RealBio Technology, Inc., a company working to develop a better system for growing cell cultures, and Vestaron Corp., a developer of innovative pesticides from snake venom, have been asked to be part of the Michigan Growth Capital Symposium, May 11-12, in Ypsilanti, Mich. 

The symposium invites leaders in the venture capital investment world to connect with entrepreneurs, startups and emerging growth companies that are actively searching for partners and funding.

The event will host more than 400 attendees and 65 investment firms. The 32 emerging and growth business ventures slated to present made it through a rigorous screening process.
 
The businesses seeking capital that would take them to the next level come from the areas of life sciences, energy, IT and technology.

At Vestaron, scientists are unlocking the mystery of how spiders kill insects -- work that is leading to a new generation of insecticides.  So far, more than 50 unique insecticidal spider peptides have been identified. A patented technology, exclusively licensed to Vestaron, has proven highly effective against insects and related pests and harmless to non-target species, including humans. Target markets include agriculture, animal health and specialty non-crop uses such as household insects.  

RealBio has developed a new cell culture that allows human stems cells to grow and be maintained for more than a year. Stem cells also can be harvested for the same amount of time without adverse affects. RealBio's technology can be tailored to culture numerous tissue types.

Overall, RealBio's Culture System promotes the growth, function, and harvest of a variety of human and animal cells for use in a range of research, study and production applications.

Writer: Kathy Jennings
Source: Jean Serra, Michigan Growth Capital Symposium

Enjoy this story? Sign up for free solutions-based reporting in your inbox each week.